Type(s) of Cancer
Leukemia/Lymphoma
Leukemia/Lymphoma
Study Phase
Phase 3
Study Completion Date
March 2019
March 2019
NCT01190930Uploaded 02-07-2024
Access via NCI by Request
PDS UID: nci-data-532
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Files: NCT01190930-D1
Data DictionaryNCT01190930-D1-Data-Dictionary_1.pdf
DATANCT01190930-D1-Dataset_2.csv
OTHERREADME.pdf
Files: NCT01190930-D2
Data DictionaryNCT01190930-D2-Data-Dictionary_1.pdf
DATANCT01190930-D2-Dataset_3.csv
OTHERREADME.pdf